Sumitomo Pharma Balance Sheet Health
Financial Health criteria checks 0/6
Sumitomo Pharma has a total shareholder equity of ¥343.6B and total debt of ¥411.8B, which brings its debt-to-equity ratio to 119.9%. Its total assets and total liabilities are ¥1,060.0B and ¥716.4B respectively.
Key information
119.9%
Debt to equity ratio
JP¥411.84b
Debt
Interest coverage ratio | n/a |
Cash | JP¥42.81b |
Equity | JP¥343.59b |
Total liabilities | JP¥716.38b |
Total assets | JP¥1.06t |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: DPM's short term assets (¥264.2B) do not cover its short term liabilities (¥421.2B).
Long Term Liabilities: DPM's short term assets (¥264.2B) do not cover its long term liabilities (¥295.2B).
Debt to Equity History and Analysis
Debt Level: DPM's net debt to equity ratio (107.4%) is considered high.
Reducing Debt: DPM's debt to equity ratio has increased from 6.4% to 119.9% over the past 5 years.
Debt Coverage: DPM's operating cash flow is negative, therefore debt is not well covered.
Interest Coverage: Insufficient data to determine if DPM's interest payments on its debt are well covered by EBIT.